Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Duel: Dual Eligibles, FEHBP, Private Employer Coverage Debated

Executive Summary

Prescription drug costs of the dual-eligible population should be borne completely by the federal government under a new Medicare drug benefit rather than by the states under Medicaid, the National Governors Association 2003 Medicaid Reform Principles say

You may also be interested in...



Medicare AWP Reform: “Get The Doctors Out Of The Pharmacy Business”

The problems with Medicare's AWP payment system for oncology products suggests that the federal government needs to "get the doctors out of the pharmacy business," Aetna CEO John Rowe declared during a March 21 Medicare Payments Advisory Commission meeting

Medicare AWP Reform: “Get The Doctors Out Of The Pharmacy Business”

The problems with Medicare's AWP payment system for oncology products suggests that the federal government needs to "get the doctors out of the pharmacy business," Aetna CEO John Rowe declared during a March 21 Medicare Payments Advisory Commission meeting

Medicare Rx Hinges On Senate Finance Cmte.; White House Delays Details

The prospects for a Medicare drug benefit in 2003 are likely to hinge on the ability of the Senate Finance Committee to find a bipartisan consensus over the next several months

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041359

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel